Xue-ying Ren
No. 7 Xishiku Street
Beijing, 100034, China
Beijing, 100034, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Long-term Outcomes of Toxicities and Disease Control Following Postoperative Moderately Hypofractionated Radiotherapy in High-Risk Prostate Cancer: Results of a Prospective Study.
Journal: Clinical and translational radiation oncology
Published: November 30, 2025
Induction Chemoimmunotherapy Followed by Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Journal: Cancer management and research
Published: May 14, 2025
Evolving trends and clinical-pathological correlations in renal cell carcinoma surgery: a decade-long study at Peking University First Hospital.
Journal: Clinical and experimental medicine
Published: March 31, 2025
Efficacy and safety of SABR/partial-SABR combined with axitinib and toripalimab in recurrent or metastatic renal cell carcinoma: Preliminary results from a prospective phase 2 trial.
Journal: Oncology letters
Published: March 08, 2025
Enhancing precision in lacrimal sac tumor management through integration of multimodal imaging and intensity modulated proton therapy.
Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists
Published: August 25, 2024
Outcomes of Radical Radiotherapy for the Treatment of Localized Renal Pelvic and Ureteral Carcinoma Intolerant to Surgery: A Real-World Study.
Journal: Clinical genitourinary cancer
Published: March 13, 2024
Biomarkers for Prostate Cancer: From Diagnosis to Treatment.
Journal: Diagnostics (Basel, Switzerland)
Published: September 01, 2023
Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: May 24, 2023
Breaking barriers: Stereotactic ablative proton and photon radiation therapy for renal cell carcinoma with extensive metastases: A case report.
Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists
Published: May 09, 2023
Safety and efficacy of radiotherapy combined with chemotherapy for recurrent metastatic renal pelvic and ureteral carcinoma.
Journal: World journal of urology
Published: February 28, 2023
Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients.
Journal: Current oncology (Toronto, Ont.)
Published: August 24, 2022
Last Updated: 09/26/2026